September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
GPR109A activation reduces macrophage infiltration and subsequent neurodegeneration in a non-autoimmune model of uveitis
Author Affiliations & Notes
  • Matthew Kaufman
    Biochemistry and Molecular Biology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
  • Britta White
    Biochemistry and Molecular Biology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
  • Folami Lamoke
    Biochemistry and Molecular Biology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
  • Sathish Sivaprakasam
    Biochemistry and Molecular Biology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
  • Nagendra Singh
    Biochemistry and Molecular Biology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
  • Pamela M Martin
    Biochemistry and Molecular Biology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
    Ophthalmology & Culver Vision Discovery Institute , Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States
  • Footnotes
    Commercial Relationships   Matthew Kaufman, None; Britta White, None; Folami Lamoke, None; Sathish Sivaprakasam, None; Nagendra Singh, None; Pamela Martin, None
  • Footnotes
    Support  5R01EY022704-02
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5400. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Matthew Kaufman, Britta White, Folami Lamoke, Sathish Sivaprakasam, Nagendra Singh, Pamela M Martin; GPR109A activation reduces macrophage infiltration and subsequent neurodegeneration in a non-autoimmune model of uveitis. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5400.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Unregulated inflammation is implicated in a number of degenerative retinal diseases. Our prior in vitro studies demonstrate GPR109A, a G-protein coupled receptor expressed in monocytes/macrophages and retinal pigment epithelial cells, to be a potent modulator of inflammation. Our aim here was evaluate the protective effects of GPR109A activation in retina in vivo. To do so, we used mice with endotoxin-induced uveitis, a widely accepted model of acute retinal inflammation.

Methods : Wild-type (WT; Gpr109a+/+) and knockout (KO; Gpr109a-/-) C57BL/6J male mice (5 months old) were injected intraperitoneally with PBS (control) or GPR109A agonists, β-hydroxybutyrate (β-HB; 300 mg/kg) or niacin (60 mg/kg) for 4-consecutive days. On day 4, lipopolysaccharide (LPS; 4 mg/kg) was also injected. 16-24 h post-injection, whole blood and eyes were harvested. Circulating immune cells were quantified using a hematology analyzer (Horiba). Mouse multiplex chemokine arrays (R&D Systems), Western blotting, and immunohistofluorescence analyses were used to evaluate the retinal inflammatory protein profile. Retina/RPE tissues were homogenized and single cell suspensions were prepared and the number of cells positive for CD45, CD11b and F4/80 were quantified by flow cytometry. Cell death was assessed by routine TUNEL assay and caspase 3 Western blotting.

Results : Significantly higher numbers of pro-inflammatory cytokines, chemokines and CD45/CD11b/F4-80 -positive cells were evident in control KO compared to WT retinas. LPS injection induced robust increases these parameters both in WT and KO retinas. Pre-treatment with niacin or β-HB abrogated significantly the LPS-induced effect in WT retinas but had little to no effect in KO retinas. Hematological analyses revealed a similar trend with respect to the number of circulating monocytes. The number of apoptotic (TUNEL and caspase 3 positive) retinal cells was reduced also with ligand treatment of WT retina, but no cell protective effects were evident in treated KO retinas.

Conclusions : Our current findings suggest GPR109A to be an ideal therapeutic target for curtailing pathologic inflammation in the retina, thereby preventing and treating retinal neurodegenerative diseases.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×